Control of hyperphosphatemia in chronic renal failure. Ca deficiency states which may occur in acute & chronic hypoparathyroidism, postmenopausal & senile osteoporosis, rickets & osteomalacia. Ca supplement in childn, pregnant & lactating women.
May gradually increase dose to bring serum phosphate <6 mg/dL, as long as hypercalcemia does not develop. Adult dialysis patient Initially 1 tab w/ each meal. Most patients require 2-3 tab w/ each meal. Hypocalcemia 1-2 tab bid after meals.
Reduce dose or discontinue immediately if hypercalcemia develops. Not to be given in patients on digitalis. Monitor serum Ca twice wkly during dose adjustment. Concurrent use w/ other Ca supplements. End-stage renal failure.
Sign Out
